Multiple Sclerosis Trial, Recruiting NCT05258396 Sponsor: Assistance Publique - Hôpitaux de Paris Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

NCT05258396
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For patients with MS:

  • You are between 12 and 18 years old
  • You have been diagnosed with relapsing-remitting multiple sclerosis (a form of MS where symptoms come and go) based on recognised medical guidelines
  • You have not had an MS relapse (a flare-up of symptoms) in the last 4 weeks
  • You have not taken steroid medications (methylprednisolone or prednisolone) in the last 4 weeks
  • You are covered by the French social security system
  • Both parents or legal guardians have agreed and signed the consent form

For healthy volunteers:

  • You are between 12 and 18 years old
  • You do not have any neurological (brain or nerve) conditions
  • Both parents or legal guardians have agreed and signed the consent form

Who may not be able to join:

  • Either parent or legal guardian does not agree to participation
  • You have a reason you cannot safely have a brain MRI scan, such as having a pacemaker, a tattoo on your face, or a fear of enclosed spaces (confirm with trial site for full list)
  • You are pregnant or have a copper coil (a type of contraceptive device) fitted

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 1 42 16 19 75

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
11 August 2022
Est. completion
11 September 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

MTR-based individual indices

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov